RMD
ResMed Inc.NYSE
1d
5d
1m
6m
1y
5y
10y
Advanced Chart
  • Mon, Feb. 22, 4:14 PM
    • ResMed (NYSE:RMD) acquires privately held Brighttree, a developer of business management and clinical cloud-based software applications for the post-acute care industry, for $800M in cash.┬áResMed will fund most of the purchase with debt.
    • The transaction will be immediately accretive to gross margins and non-GAAP EPS. It includes an estimated $300M from an anticipated future tax benefit, expected to positively affect ResMed's cash flow over 15 years.
    • Brightree booked $113M in sales and $43M in EBITDA last year.
    | Mon, Feb. 22, 4:14 PM | 2 Comments